The objective of this study is to evaluate the safety and preliminary efficacy of TRS01 eye drops as compared to placebo on participants with ocular inflammation after cataract surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
37
Dosed 4 times a day (QID)
Dosed QID
Dosed QID
Inglewood
Inglewood, California, United States
Petaluma
Petaluma, California, United States
Washington, MO
Washington, Missouri, United States
New York
New York, New York, United States
Cincinnati
Assessment of Both Systemic and Ocular Adverse Events
Number of adverse events that occurred during the study
Time frame: 14 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Dosed QID
Cincinnati, Ohio, United States